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Abstract.  The enzymatic activity of filamentous de- 
phosphorylated smooth muscle myosin has been 
difficult to determine because the polymer disassem- 
bles to the folded conformation in the presence of 
MgATP.  Monoclonal antirod antibodies were used 
here to "fix" dephosphorylated myosin in the filamen- 
tous state.  The steady-state actin-activated ATPase of 
phosphorylated filaments was 30-100-fold higher than 
that of antibody-stabilized dephosphorylated filaments, 
suggesting that phosphorylation can activate ATPase 
activity independent of changes in assembly. The de- 
gree of regulation may exceed 100-fold,  because 
steady-state measurements slightly overestimate the 
rate of product release from dephosphorylated fila- 
ments. Single-turnover experiments in the absence of 
actin showed that although dephosphorylated folded 
myosin released products at the low rate of 0.0005 
s-'  (Cross, R. A., K. E. Cross, A. Sobieszek.  1986. 
EMBO [Fur. Mol.  Biol.  Organ.] J.  5:2637-2641)the 
rate of product release from dephospborylated fila- 
ments was only 3-12-fold higher, depending on the 
ionic strength. The addition of actin did not increase 
this rate to any appreciable extent. Dephosphorylated 
filaments and dephosphorylated heavy meromyosin 
(Sellers, J.  R.  1985. J. Biol.  Chem.  260:15815-15819) 
thus have similar low rates of phosphate release both 
in the presence and absence of actin. These results 
show that light chain phosphorylation alone, without 
invoking other mechanisms, is an effective switch for 
regulating the activity of smooth muscle'myosin fila- 
ments. 
p 
HOSPHORYLATION  of the 20-kD regulatory light chain 
by myosin light chain kinase is closely coupled to the 
initiation of contraction in smooth muscles (for review 
see Kamm and Stull,  1985). Consistent  with this observa- 
tion, biochemical studies with heavy meromyosin (HMM),I 
the soluble,  regulated subfragment of myosin, showed that 
light chain phosphorylation increased the rate of product re- 
lease by nearly 1,000-fold in the presence of actin, from 
0.002 to 1.9 s  -~ (Sellers,  1985). In vitro studies with whole 
myosin, however, suggested that the state of assembly of the 
myosin may be more important in determining activity than 
the state of phosphorylation of the regulatory light  chain 
(Wagner and Vu,  1986, 1987). 
Myosin can adopt two conformations in the presence of 
MgATP, depending on the solvent conditions and the state 
of phosphorylation of the myosin. In a typical solvent used 
for ATPase assays, namely, low ionic strength  (50--75 mM 
KCI) and moderate concentrations of magnesium (2-4 mM), 
dephosphorylated myosin would mainly be in the assembly- 
incompetent folded conformation, with the myosin rod bent 
into thirds and the heads pointed down toward the tail (Try- 
bus and Lowey, 1984). Phosphorylated  myosin would be pre- 
dominantly filamentous. When the actin-activated activity of 
these two species was compared, the degree of regulation by 
phosphorylation was high, and myosin appeared to be simi- 
lar to HMM (Wagner and Vu,  1986, 1987). 
1. Abb~viations used in this paper: FTP, formycin triphosphate; HMM and 
LMM,  heavy and light meromyosin, respectively. 
To polymerize dephosphorylated myosin, high concentra- 
tions of magnesium (>-10 mM) are necessary. Unexpectedly, 
the actin-activated  ATPase of these dephosphorylated illa- 
ments was only two- to threefold  less than that of phos- 
phorylated filaments (Wagner and Vu,  1986, 1987). This 
observation  suggested that phosphorylation might increase 
activity primarily by altering the conformational state of the 
myosin,  and not by directly affecting the rate of product 
release.  Because filaments have been observed in relaxed 
smooth muscles (Somlyo et al.,  1981; Gillis et al.,  1988), 
their enzymatic activity must be "turned off" by some mecha- 
nism. If dephosphorylation  does not inhibit the rate of ATP 
turnover from filaments, another regulatory system has to be 
invoked. 
Here, antibodies were used instead of magnesium to stabi- 
lize dephosphorylated filaments.  This permitted the enzy- 
matic activity of dephosphorylated filaments to be examined 
under more physiological conditions,  where myosin would 
normally disassemble.  The results  suggest that changes in 
the state of light chain phosphorylation alone can effectively 
regulate the activity of filamentous myosin. 
Materials and Methods 
Protein Preparation 
Turkey gizzard myosin was pr~rvd  as described by Sellers et al. (1981). 
This myosin was ;~95 % dephosphorylated as determined by glycerol/poly- 
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phosphorylated at low ionic strength as previously described (Trybus and 
Lowey, 1984). Smooth muscle myosin light chain kinase was isolated essen- 
tially according to Adelstein and Klee (1981), and ealmodnlin was purchased 
from Pharmacia Fine Chemicals (Piseataway,  NJ). Turkey gizzard tropo- 
myosin was  isolated from  an  ethanol-acetone gizzard powder (Smillie, 
1981). Actin was purified from chicken pectoralis acetone powder as de- 
scribed by Pardee and Spudich (1982). Monoclonal antibodies were purified 
from ascitic fluid on an Affi-Gel Protein A column (Bio-Rad Laboratories, 
Richmond, CA). Protein concentrations were determined at ~, =  280 am 
with the following extinction coefficients (1 mg/ml): myosin, 0.5; actin, 1.1; 
tropomyosin, 0.29; IgG,  1.45. 
l~lament Formation 
Myosin in 10 mM KPi, pH 7.5, 0.6 M KCI, 1 mM EGTA,  1 mM DTT,  1 
mM NaN3 was dialyzed into 20 mM imidazole, pH 7, 150 mM KC1, 3 mM 
MgSO4,  1 mM EGTA,  1 mM DTT.  If the final assay conditions were 50 
or 75 mM KCI, the filaments formed in 150 mM KCI were diluted with an 
appropriate amount of buffer without added salt. Antibody was either added 
to the filaments in 150 mM KCI, or after the filaments were diluted to the 
correct final salt concentration. The order of addition of antibody to fila- 
ments did not appear to affect the enzymatic activity. 
l~lament Pelleting  Assay 
The  fraction of filamentous myosin was estimated from the amount of 
peiletable material after a  10-rain  spin at 23 psi (130(300 g) in an airfuge 
(Beckman Instruments, Inc., Fnllerton, CA). Supernatant protein concen- 
trations were determined by the Bradford method (1976) with a myosin stan- 
dard curve. 
Steady-state ATPases 
Phosphate release was determined colorimetrically (Taussky  and Short, 
1953)  after the reaction was stopped with SDS  as described by White 
(1982).  The myosin concentration was 0.25 mg/ml (1-~M sites), and the ac- 
tin-tropomyosin (4:1 molar ratio) and antibody concentrations were as indi- 
cated in the figure legends and tables. The reaction was started by the addi- 
tion of 2 mM MgATP,  and the reaction stopped at three times during the 
initial 30%  of the reaction.  Rates were obtained from the average slope 
through these three time points. 
Release of ~/32p  from Myosin 
A rapid gel filtration method (Neal and Florini, 1973) was used to measure 
the release of bound phosphate from myosin. The Sephadex G-50 columns 
were prepared as described by Sellers (1985).  2/~M (3,32p)MgATP (1  × 
106 cprrdnmoi) was added to l-/tM myosin sites (0.25  mg/ml); 10 s later 1 
mM unlabeled MgATP was added. 100 ~tl was applied to the l-ml column 
at various times, and the column immediately spun to separate free phos- 
phate from myosin. The amount of phosphate bound to myosin, determined 
by counting an aliquot of the void volume, was plotted as a function of time. 
Reaction time is considered to be the time between addition of labeled 
MgATP and when the centrifuge was started; the length of  the spin was 30 s. 
The moles phosphate per mole active site was calculated based on the con- 
centration of myosin that was eluted from the column, which was typically 
60-70% of the applied concentration. 
Release of Formycin Triphosphate 
2  /tM  formycin  triphosphate  (FTP)  (Calbiochem-Behring  Corp.,  San 
Diego, CA) was added to 1-/~M myosin sites (0.25 mg/ml) until the fluores- 
cence reached a maximum. Approximately 30 s later,  100 #M MgATP was 
added, and the decrease in FTP fluorescence followed as a function of time. 
The measurements were made with a fluorimeter (MPF44; Perkin-Elmer 
Corp., Norwalk, CT) thermostatted at 24°C; 4 mm square micro cells were 
used. The exciting wavelength was 313 nm '(2-nm slit), and the emission 
monitored at 340 nm (2-nm slit). 
Electron Microscopy 
Filaments (25-50 #g/ml) were applied to a carbon-coated grid, negatively 
stained with 1% uranyl acetate, and examined with a Philips electron micro- 
scope (EM301;  Philips Electronic Instruments, Inc., Mahwah, N J) operated 
at 80 kV. 
Results 
Actin-activated ATPase Activity of Folded  and 
Filamentous Gizzard Myosin 
The actin-tropomyosin activated .gl"Pase activity of myosin 
was determined under conditions where the dephosphory- 
lated species  was  folded and phosphorylated myosin was 
filamentous (Fig.  1, circles).  A  >~50-fold difference in the 
Vmax of these two species (0.03  vs.  1.7  s-0  was observed, 
suggesting that phosphorylation effectively regulates actin- 
activated ATPase activity when changes in conformational 
state occur. 
The degree to which phosphorylation increases enzymatic 
activity when myosin is filamentous has been more difficult 
to establish, primarily because unusual solvent conditions 
(low pH or high concentrations of magnesium) must be used 
to  prevent dephosphorylated myosin from disassembling. 
The activity of dephosphorylated filaments has been report- 
ed to approach to within threefold of the value obtained for 
phosphorylated  filaments  under  some  solvent  conditions 
(Wagner and Vu, 1986, 1987). The loss of  regulation was due 
to an increase in the rate obtained with the dephosphorylated 
species,  a  trend that was  also observed here.  In  10 mM 
MgSO4 (50 mM KCI, pH 7),  both dephosphorylated and 
phosphorylated myosin were filamentous, and the difference 
in Vmax between the two species decreased to a factor of 11 
(0.15 vs.  1.6 s-~; Fig.  1,  squares).  Although these results 
suggest that phosphorylation has only small effects on activ- 
ity when myosin is filamentous, it is possible that factors 
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Figure  1.  Actin-tropomyosin-activated ATPas¢ activity of gizzard 
myosin in 3 and  10 mM MgSO4. The ATPasc activity of phos- 
phorylated (e, m) and dephosphorylated (o, n) myosin is plotted 
as a function of actin-tmpomyosin (4:1 molar ratio) concentration. 
At both 3 (e) and 10 (t=) mM MgSO4, the Vm~ for phosphorylated 
myosin was 1.6-1.7 s  -~, and the K= was 1-2 #M. For dcphosphory- 
lated myosin in 3 mM MgSO4, the rate at 50/~M actin-tropomyo- 
sin was 0.03 s  -l (o). In  10 mM MgSO4, the maximum rate ob- 
tained with dcphosphorylated myosin increased  to 0.17 s  -I, and the 
Km was <1 #M (O). Pelleting assays  estimated the percent soluble 
myosin under these conditions: at 3 mM MgSO4, 76% of the dc- 
phosphorylated myosin and 14% of the phosphorylated  myosin was 
soluble; at  10 mM  MgSO4, only  ]3%  of the dephosphorylated 
myosin and 7 % of the phosphorylated myosin was soluble. Condi- 
tions: 20 mM imidazolc, pH 7, 50 mM KC1, 1 mM EGTA, 0.5 mM 
DTT,  37°C,  3  or  10 mM MgSO4. 
The Journal  of Cell Biology,  Volume 109, 1989  2888 Figure 2. Antirod antibodies stabilize dephosphorylated filaments in the presence of nucleotide. Filaments were reacted with a 3:1 molar 
ratio of antibody/myosin. I mM MgATP was then added, and the filaments were negatively stained. Phosphorylated filaments were reacted 
with LMM.2 in A or with LMM.I in B. Dephosphorylated filaments were reacted with LMM.2 in C or LMM.1 in D. Note the striations 
with a 15-nm periodicity. The inset in C shows filaments in the absence of antibody and nucleotide. Conditions: 20 mM imidazole, pH 
7,  150 mM KCI, 3 mM MgSO4, 1 mM EGTA, mM MgATP. Bar, 0.1 #m. 
other than the change in conformation may have activated the 
dephosphorylated myosin. 
Actin-activated ATPase Activity of 
Antibody-stabilized Filaments 
The effect of conformation on activity was directly deter- 
mined by comparing the rates of folded and dephosphory- 
lated filamentous myosin in  the same  solvent.  Antibodies 
with epitopes located in the central portion of the rod ($2.2, 
LMM.I, and LMM.2) were used to stabilize dephosphory- 
lated filaments in the presence of MgATP (Trybus and Hen- 
ry,  1989).  Electron  micrographs  of the  antibody-myosin 
complexes confirmed that dephosphorylated myosin remained 
assembled in the presence of nucleotide (Fig. 2,  C and D). 
The antibody-stabilized filaments have a  distinctive struc- 
ture: periodic striations at 15-nm intervals are evident along 
the  filament length.  Filaments  decorated with  any  of the 
three antibodies show this pattern, but it is most prominent 
in those filaments decorated with LMM.2 (Fig. 2, A and C). 
Similar striations are, seen in the presence and absence of 
nucleotide, and with dephosphorylated (Fig. 2, C and D) and 
phosphorylated (Fig. 2, A and B) filaments. Striations were 
also  seen with  antibody-decorated filaments formed from 
rod, indicating that the striped pattern was caused by bound 
antibody, and was not due to ordering of the crossbridges. 
The steady-state actin-activated ATPase activity of anti- 
body-stabilized filaments  was  measured  under  conditions 
where dephosphorylated myosin normally assumes the folded 
conformation, and where phosphorylation therefore has  a 
large effect on activity (50 mM KC1, 3 mM MgSO4,  as in 
Fig.  1). An actin-tropomyosin concentration of 30 #M was 
used so that maximal velocities would be measured. The an- 
tirod antibodies did not interfere with actomyosin interac- 
tions because the activity of phosphorylated filaments was 
unchanged in the presence of antibody (Table I).  The rate 
of the antibody-stabilized dephosphorylated filaments, how- 
ever, was as low as that obtained in the absence of antibody, 
suggesting that assembly into a  filament does not activate 
the ATPase. Under these conditions, dephosphorylated myo- 
sin had a  30-fold lower rate than phosphorylated filaments 
(Table I). 
The filaments formed at 50 mM KC1 tended to aggregate 
side by side, although periodic striations were still evident 
on the antibody-decorated filaments. At the slightly higher 
salt concentration of 75 mM, the polymers showed less of a 
tendency to associate, and the actin-activated ATPase activ- 
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Actin-  Percent 
activated  soluble 
Myosin  Antibodyll  -Actin  +Actin¶  rate  myosin 
$-I  $-I  $-I 
Dephosphorylated*  None  0.017  0.063  0.046  76 
$2,2  0,020  0,059  0,039  0 
LMM. 1  0,032  0.062  0.032  0 
Dephosphorylated¢  none  0.087  0.195  0.108  13 
Dephosphorylated§  none  0.140  94 
Phosphorylated*  none  0.099  1.56  1.46  14 
$2.2  0.083  1.30  1.22  0 
LMM. 1  0.088  1.65  1.56  0 
Phosphorylated~;  none  0.178  1.49  1.32  7 
* 20 mM imidazole, pH 7, 50 mM KCI, 3 mM MgSO4,  1 mM EGTA, 0.2 
mM DTT, 37"C. 
As in *, but 10 mM MgSO4. 
§ As in *, but 0.6 M KCI. 
II 3:1 molar ratio of antibody/myosin. Antibody was added to filaments in 50 
mM KCI. 
¶ 30 aM skeletal  muscle actin, 7.5 aM gizzard tropomyosin. 
ity of dephosphorylated and phosphorylated filaments was 
also determined in this solvent. Pelleting assays confirmed 
that antibody remained bound to the filaments in the pres- 
ence of actin. 
In 75 mM KC1, the Km was 2/~M, and maximal velocities 
could again be obtained. Similar to the results obtained in 
50  mM KCI, the dephosphorylated filaments turned over 
MgATP at a rate 40-100-fold slower than the phosphorylated 
filaments (Table II). A large degree of regulation by phos- 
phorylation was observed at both 24 and 37°C, at 1:1 and 3:1 
molar ratios of antibody/myosin, and regardless of whether 
the antibody was added to filaments formed in 75 or 150 mM 
KCI. Slightly lower degrees of regulation were obtained with 
antibody $2.2 compared with the two anti-LMM antibodies, 
but the difference between phosphorylated and dephosphor- 
ylated myosin was still 40-50-fold. 
The results obtained at both ionic strengths strongly sug- 
gest that phosphorylation can regulate the activity of fila- 
mentous myosin in solvents containing near physiological 
concentrations of magnesium. The reduced degree of regula- 
tion by phosphorylation observed at high magnesium con- 
centrations does not appear to be a direct consequence of the 
assembly of the dephosphorylated myosin. 
Release of  Products from Folded and Filamentous 
Myosin in a Single Turnover 
The effect of conformation on activity was further inves- 
tigated by the use of single-turnover assays, in which only 
one ATP was added per active site. The rate of a very slowly 
cycling species can be overestimated in the steady state if 
there is even a small amount of myosin with a faster turnover 
rate for ATP (Wells and Bagshaw,  1985; Cross et al., 1986). 
To determine if myosin in a filament attains the same low rate 
of product release as the folded conformation, a rapid gel 
filtration method was used to measure the rate of release of 
radioactive phosphate in the absence of actin. As reported by 
Cross et al. (1986), the folded conformation in 150 mM KCI 
essentially traps the products of ATP hydrolysis, and phos- 
phate is released at the very slow rate of 0.0005 s -L (Fig. 3, 
filled circles; Table III). The rate of phosphate release from 
antibody-stabilized dephosphorylated filaments at this ionic 
strength was 0.006 s  -t (Fig. 3, open symbols). This value is 
an order of magnitude greater than that observed with the 
folded monomer, which appears to be essentially inactive, 
but it is still a very low rate of ATP turnover.  Phosphoryla- 
tion of the filaments further increased the rate of phosphate 
release by approximately a factor of four, resulting in a rate 
similar to that obtained with the extended monomer in high 
salt (Fig. 3, filled squares and triangles). Thus, at 150 mM 
salt, essentially three levels of activity can be distinguished. 
To compare the rates obtained by single turnovers with the 
rates obtained for the steady-state ATPases,  these experi- 
ments were repeated at lower ionic strength with the fluores- 
cent nucleotide FTE This analog has been shown to substi- 
Table II. Actin-activated ATPase Rates of  Antibody-stabilized Filaments 
Dephosphorylated myosin  Phosphorylated myosin 
Actin-  Actin- 
activated  activated 
C  Antibody  - Actin  + Actin  §  rate  -  Actin  + Actin§  rate 
Degree 
of 
regulation 
37°C 
24°C 
S-I  S-I  S-I  S-I  S-/  $-I 
none  0.009  0.020  0.011  0.106  1.68  1.57 
$2.2  0.020  0,047  0.027  0.099  1.29  1.19 
LMM.I  0.038  0.057  0.019  0.083  1.51  1.43 
LMM.2  0.033  0.037  0.004  0.095  1.54  1.45 
LMM.2*  0.027  0.042  0.015  0.116  1.42  1.30 
LMM.2*  0.026  0.046  0,020  0.108  1.35  1.24 
none  0.002  0.004  0.002  0.013  0.245  0.232 
$2.2  0.005  0.008  0.003  0.014  0.171  0.157 
LMM. 1  0.007  0,007  -  0.021  0.261  0.240 
LMM.2  0.005  0.007  0.002  0,014  0,239  0.225 
143 
44 
75 
>/100 
87 
62 
116 
52 
>/100 
112 
Conditions: 20 mM imidazole, pH 7, 75 mM KCI, 3 mM MgSO4,  1 mM EGTA, 0.2 mM DTT. A threefold molar excess of antibody 
in 0.15 M  KCI; the salt concentration was then lowered to 75 mM KCI. 
*  1 : l  molar ratio of antibody/myosin. 
~: A threefold molar excess of antibody was added to filaments in 75 mM KCI. 
§ 20 #M skeletal  muscle actin, 5 #M gizzard tropomyosin. 
was added to filaments 
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Figure 3. Release of 732p in a sihgle 
turnover. The release of radioactive 
phosphate as a function of time was 
followed by a rapid gel filtration meth- 
od (see Materials and Methods). The 
folded monomer (e) released phos- 
phate at a rate of 0.00053 s-L  An- 
tibody-stabilized  dephosphorylated 
filaments (zx, $2.2;  o,  LMM.1;  ra, 
LMM.2) had a 10-fold higher rate of 
0.006 s-L  Phosphorylated  filaments 
in the absence  (u) or presence  (A, 
LMM.1) of antibody,  or myosin in 
high salt (v) was at least four times 
faster;  70%  of the  phosphate  was 
released by the time the first point of 
this  manual  assay  could  be taken. 
Conditions: 20 mM imidazole, pH 7, 
150 mM KCI, 3 mM MgSO4, 1 mM 
EGTA, 0.5 mM DTT, 24°C. 
tute for ATP in inducing the folded conformation (Cross et 
al.,  1988). The fluorescence of the FTP approximately dou- 
bled upon binding to the active site; release of nucleotide was 
followed by the decrease in fluorescence with time. The rate 
of FDP release from the folded monomer at 150 mM KCI 
was 0.0006 s  -~, which agreed reasonably well with the rate 
of phosphate release determined by the column method. 
At 50 mM KCI, dephosphorylated filaments released prod- 
ucts at 0.0014  s -j (Fig. 4 B and Table III), a rate ,'ofourfold 
lower than that obtained at 150 mM KC1. Dephosphorylated 
myosin not stabilized by antibody released products at essen- 
tially the same rate (0.0012  s-~; Fig. 4 A and Table IH), al- 
though this value probably reflects some contribution from 
filaments that did not disassemble. A decrease in the rate of 
product release with decreasing salt concentration has also 
been observed with HMM (Greene and Sellers, 1987). Phos- 
phorylation caused a five- to sevenfold increase in the rate 
of FDP release (Fig. 4 C, Table III). These rates are within 
threefold of the values obtained in the steady state. 
These results show that all myosins with an extended tail 
are not equivalent. At low ionic strength, dephosphorylated 
myosin in a filament releases products at a rate 10-20-fold 
lower than that from an extended monomer in high salt. 
Upon addition of 5 #M actin-tropomyosin to the dephos- 
phorylated dimers or the antibody-stabilized dephosphory- 
lated filaments in 50 mM KCI, the rate increased less than 
twofold,  to 0.0019  s -~  (Fig.  4, A  and B;  Table III). These 
values are within fourfold of the rates obtained in the steady 
state. The Km for actin is 1 #M under these conditions, and 
thus these rates should be near V,=.  It was not feasible to 
use higher actin concentrations, because of mixing problems 
and because the optical density at the exciting wavelength 
was too high. As expected, addition of actin-tropomyosin to 
the phosphorylated filaments resulted in a rate of  FTP release 
that was too fast to measure by this method (Fig. 4  C). 
By combining the data obtained in the steady state and by 
single turnovers, it can be seen that dephosphorylated illa- 
ments turn over ATP at the rate of 0.001-0.002  s  -~  in low 
Table III. Single-turnover Rates of  Myosin Monomers and Filaments 
FTP$  ATP,  steady-state 
50 mM KCI  50 mM KCI 
ATP(-r32p)  * 
150 mM KCI  Actin-  Actin- 
activated  activated 
Myosin  Antibody  - Actin  - Aetin  + Actin§  rate  rate| 
S-I  $-I  S-I  $-I  $-I 
dephosphorylated  none  0.0005  0.0012  0.0019  0.0007  0.0045 
LMM. 1  0.006  0.0014  0.0019  0.0005  0.0051 
Phosphorylated  none  =0.02  0.006  fast  0.33 
LMM. 1  =0.02  0.006 
Conditions:  20 mM imidazole,  pH 7, 50 or 150 mM KCI, 3 mM MgSO4, 1 mM EGTA,  0.2  mM DTT,  24"C. 
* Release of bound phosphate was followed by rapid gel filtration.  Rates were estimated from semi-log plots. 
$ The fluorescent ATP analog,  FTP,  was used to follow, nucleotide release.  Rates were estimated from half-times of the reaction. 
§ 5 p.M skeletal muscle actin,  1.3 p~M gizzard tropomyosin.  Under these solvent conditions,  the Km of the steady-state actin-activated ATPase is •1  /~M actin- 
tropomyosin. 
II 20/~M  skeletal muscle aetin,  5 #M gizzard tropomyosin. 
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Figure 4. Release of FTP from filaments or bided myosin in the 
presence and absence of actin. 2 #M FTP was added to 1 tzM myo- 
sin. When maximum fluorescence enhancement was observed,  a 
100-#M ATP chase was added. The decay in fluorescence was then 
followed as a function of time in the absence or presence of 5 #M 
actin-tropomyosin. (A) Folded dephosphorylated myosin. The rates 
are 0.0012 s  -t in the absence of aetin, and 0.0019 s  -t in the pres- 
ence of actin. (B) Dephosphorylated filaments stabilized with anti- 
body LMM.1. The rates are 0.0014 s  -' in the absence of actin, and 
0.002 s  -t in the presence of actin.  (C) Phosphorylated filaments. 
The rate in the absence of actin was 0.006 s  -t, and too fast to mea- 
sure in the presence of actin.  Conditions:  20 mM imidazole, pH 
7, 50 mM KCI, 3 mM MgSO4, 1 mM EGTA, 0.5 mM DTT, 24°C. 
The data from these experiments are tabulated in Table HI. 
salt at 24°C, and that actin causes little activation of this rate. 
Phosphorylation of the myosin increases this rate to *0.3 
s  -~ in the presence of actin, resulting in >100-fold increase 
in the rate of ATP turnover. Although these data do not ex- 
clude the possibility of a  second regulatory system, phos- 
phorylation by itself has  a  large  effect on the  activity of 
filamentous myosin. 
Discussion 
Light chain phosphorylation affects both the conformational 
state and the enzymatic activity of smooth muscle myosin, but 
it has not been established how closely coupled these two 
processes are. The question addressed here is whether phos- 
phorylation of the regulatory light chain directly affects the 
rate of product release when the assembly state is held con- 
stant.  More specifically, can phosphorylation regulate the 
activity of filamentous myosin, or is another regulatory sys- 
tern  necessary to  inhibit  the  activity  of dephosphorylated 
filaments? The results show that the actin-activated activity 
of filamentous  myosin can be increased  to  a  large extent 
(~100-fold) by changes in light chain phosphorylation. 
The idea that conformation determines activity first arose 
from the observation that folded myosin had a 10-fold lower 
steady state MgATPase than myosin with an extended tail, 
regardless of the state of light chain phosphorylation (Ikebe 
et  al.,  1983).  This  view  was  modified  somewhat by  the 
results of experiments in which single turnovers of MgATP 
were followed. Dephosphorylated folded myosin in 150 mM 
KCI "trapped" the products of ATP hydrolysis (0.0002  s-'), 
whereas phosphorylated folded myosin had a  10-fold higher 
rate of product  release  (Cross et al.,  1986,  1988).  Phos- 
phorylation could therefore modulate the rate of product re- 
lease without changing  conformation.  Cross et al.  (1988) 
also observed that the rate of nucleotide release increased 
to 0.02  s-' for myosin with an extended tail,  regardless of 
whether the myosin was monomeric or filamentous. This ob- 
servation was unexpected because it suggested that dephos- 
phorylated filaments were not "turned off' to the same extent 
as dephosphorylated HMM (Sellers,  1985). 
Here the activity of antibody-stabilized dephosphorylated 
filaments was measured in a solvent where myosin normally 
disassembles.  The results showed that all myosins with an 
extended tail did not have the same ATPase activity. The rate 
of product  release  from  dephosphorylated  filaments  was 
low and  similar to that of dephosphorylated HMM  (0.001 
s-' at 50 mM KCI; 0.006 s-' at 150 mM KCI; see Table III) 
(Sellers, 1985; Greene and Sellers, 1987). Monomeric myo- 
sin in high salt releases products at the faster rate of 0.02 
s  -'. The similarity in rates between dephosphorylated fila- 
ments and HMM suggests that both species can undergo a 
common transition that results in the observed depression of 
product release. This transition could be related to the ob- 
served salt-induced movement of the heads of HMM from 
an upward to a downward orientation (Suzuki et al.,  1985). 
Even though the heads of folded monomeric myosin bend 
down toward the tail (Onishi and Wakabayashi, 1982; Trybus 
and Lowey, 1984), the activity of this species is lower than 
that of filaments or HMM (0.0005  s-'; see Table III). But in 
the case of folded myosin, interaction of the tail with the neck 
may stabilize the inhibited state more effectively than is pos- 
sible in the filament or with HMM. 
Phosphorylation increased the rate of product release from 
filamentous myosin approximately fivefold in the absence of 
actin (0.006 s-' at 50 mM KCI; 0.02 s -t at 150 mM KCI; see 
Table III), although this is much less than the enhancement 
seen  in  the  presence  of actin.  Other. techniques,  such  as 
limited proteolysis, have also detected differences between 
phosphorylated and dephosphorylated filaments, suggesting 
that a transition at the head/rod junction upon phosphoryla- 
tion  might play  a  role  in  determining  enzymatic activity 
(Ikebe and Hartshorne,  1984). 
Taken together, the results suggest that phosphate release 
in the absence of actin is affected both by phosphorylation 
and by changes in conformation. If  conformation is kept con- 
stant, phosphorylation activates the rate of product release 
5-10-fold; if the state of phosphorylation is kept constant, as- 
sembly into a filament causes up to a  lO-fold activation of 
product release. The rates obtained in the absence of actin 
are important because these values are the basal levels from 
The Journal of Cell Biology, Volume 109,  1989  2892 which actin and phosphorylation accelerate product release. 
The more effectively the enzyme is "turned off" the greater 
will be the degree of regulation when this inhibition is re- 
moved. 
Regulation of the rate of product release in the absence of 
actin was first described for the thick filament regulated scal- 
lop myosin. ADP release was inhibited 600-fold, and the rate 
of phosphate release decreased 50-100-fold upon removal of 
calcium (Jackson and Bagshaw,  1988).  The lowest rate of 
phosphate release obtained for scallop myosin in the absence 
of calcium was similar to that obtained with smooth muscle 
myosin dephosphorylated filaments or HMM  (0.002  s-~). 
The more physiologically relevant question is to what ex- 
tent phosphorylation regulates the ATPase activity of myosin 
in the presence of aetin. Wagner and Vu (1986,  1987) report- 
ed that under solvent conditions that favored assembly (i.e., 
high magnesium concentrations),  the  Vm~ of dephosphory- 
lated  smooth muscle myosin  filaments was high,  approxi- 
mately half that obtained with phosphorylated filaments. A 
loss of regulation by phosphorylation was also observed here 
when 10 mM MgC12 was used to promote filament forma- 
tion, but the highest values obtained were not as fast as those 
reported by Wagner  and Vu (1987).  It is not unreasonable 
that the solvent conditions necessary to prevent myosin from 
disassembling could also activate the dephosphorylated mol- 
ecule.  High  concentrations  of  magnesium,  for  example, 
caused tension development in skinned gizzard fibers in the 
absence of phosphorylation (Ikebe et al., 1984). Other mod- 
ifications, such as reaction of a thiol in the COOH-terminal 
20-kD of the head region, can also mimic the effects of phos- 
phorylation (Chandra  et al.,  1985). 
The evidence presented here suggests that filament assem- 
bly per se does not cause a large increase in actin-activated 
activity.  The steady-state actin-activated  ATPase of antibody- 
stabilized dephosphorylated filaments in 3 mM MgSO4 was 
30-100-fold  lower than  that  for phosphorylated  filaments. 
Single-turnover experiments suggest that this ratio somewhat 
underestimates the degree of regulation by phosphorylation, 
which probably exceeds  100-fold. Filament assembly, how- 
ever,  is required for actin activation. When phosphorylated 
myosin was not totally assembed, the  Vm~ decreased,  indi- 
cating that folded phosphorylated myosin was not apprecia- 
bly actin activated  (Wagner and Vu, 1986, 1987). Binding of 
phosphorylated  folded myosin  to actin has  not been  mea- 
sured, but dephosphorylated  folded myosin binds  100-fold 
more weakly to actin than extended myosin (Ikebe and Harts- 
home, 1986). The lack of actin activation  of the folded form, 
whether phosphorylated or dephosphorylated, may therefore 
simply be due to its lack of interaction  with actin. In contrast, 
the lack of actin activation of dephosphorylated HMM ap- 
pears to be due to inhibition of the rate of phosphate release, 
and not a marked decrease in affinity for actin compared with 
the phosphorylated  species (Sellers et al.,  1982). 
The in vitro results obtained here are consistent with the 
observation that phosphorylation is required  for the initia- 
tion of contraction in smooth muscles (see review by Kamm 
and Stull,  1985).  These results also suggest that even if no 
assembly-disassembly  took place in vivo,  phosphorylation 
by itself would be a good regulator of actomyosin ATPase ac- 
tivity.  Another  regulatory  mechanism  such  as  caldesmon 
does not appear  to be essential.  In some smooth muscles, 
myosin filaments can partially depolymerize and reform dur- 
ing cycles of contraction and relaxation (Godfraind-DeBecker 
and Gillis,  1988; Gillis et al., 1988). Both these studies and 
those of Somlyo et al.  (1981) showed,  however, that a high 
proportion of the myosin in relaxed smooth muscle cells ex- 
ists in the form of filaments. If folded myosin forms to some 
extent in vivo, it would only confer additional  regulation  on 
an already efficient system. 
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